Skip to main content
Top
Published in: Clinical Rheumatology 1/2014

01-01-2014 | Original Article

Acute gouty arthritis complicated with acute ST elevation myocardial infarction is independently associated with short- and long-term adverse non-fatal cardiac events

Authors: Kuan-Liang Liu, Hsin-Fu Lee, Shing-Hsien Chou, Yen-Chen Lin, Chia-Pin Lin, Chun-Li Wang, Chi-Jen Chang, Lung-An Hsu

Published in: Clinical Rheumatology | Issue 1/2014

Login to get access

Abstract

Large epidemiologic studies have associated gouty arthritis with the risk of coronary heart disease. However, there has been a lack of information regarding the outcomes for patients who have gout attacks during hospitalization for acute myocardial infarction. We reviewed the data of 444 consecutive patients who were admitted to our hospital between 2005 and 2008 due to acute ST elevation myocardial infarction (STEMI). The clinical outcomes were compared between patients with gout attack and those without. Of the 444, 48 patients with acute STEMI developed acute gouty arthritis during hospitalization. The multivariate analysis identified prior history of gout and estimated glomerular filtration rate as independent risk factors of gout attack for patients with acute STEMI (odds ratio (OR) 21.02, 95 % CI 2.96–149.26, p = 0.002; OR 0.92, 95 % CI 0.86–0.99, p = 0.035, respectively). The in-hospital mortality and duration of hospital stay did not differ significantly between the gouty group and the non-gouty group (controls). During a mean follow-up of 49 ± 28 months, all-cause mortality and stroke were similar for both groups. Multivariate Cox regression showed that gout attack was independently associated with short- and long-term adverse non-fatal cardiac events (hazard ratio (HR) 1.88, 95 % CI 1.09–3.24, p = 0.024; HR 1.82, 95 % CI 1.09–3.03, p = 0.022, respectively). Gout attack among patients hospitalized due to acute STEMI was independently associated with short-term and long-term rates of adverse non-fatal cardiac events.
Literature
1.
go back to reference Bonow RO, Mann DL, Zipes DP, Libby P (2012) Braunwald's heart disease: a textbook of cardiovascular medicine, 9th edn. Elsevier, New York Bonow RO, Mann DL, Zipes DP, Libby P (2012) Braunwald's heart disease: a textbook of cardiovascular medicine, 9th edn. Elsevier, New York
2.
go back to reference Petersel D, Schlesinger N (2007) Treatment of acute gout in hospitalized patients. J Rheumatol 34(7):1566–1568PubMed Petersel D, Schlesinger N (2007) Treatment of acute gout in hospitalized patients. J Rheumatol 34(7):1566–1568PubMed
3.
go back to reference Robinson PC, Merriman TR, Herbison P, Highton J (2013) Hospital admissions associated with gout and their comorbidities in New Zealand and England 1999–2009. Rheumatology (Oxford) 52(1):118–126CrossRef Robinson PC, Merriman TR, Herbison P, Highton J (2013) Hospital admissions associated with gout and their comorbidities in New Zealand and England 1999–2009. Rheumatology (Oxford) 52(1):118–126CrossRef
4.
go back to reference Doherty M (2009) New insights into the epidemiology of gout. Rheumatology (Oxford) 48(suppl 2):ii2–ii8CrossRef Doherty M (2009) New insights into the epidemiology of gout. Rheumatology (Oxford) 48(suppl 2):ii2–ii8CrossRef
6.
go back to reference Culleton BF, Larson MG, Kannel WB, Levy D (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131(1):7–13PubMedCrossRef Culleton BF, Larson MG, Kannel WB, Levy D (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131(1):7–13PubMedCrossRef
7.
go back to reference Abbott RD, Brand FN, Kannel WB, Castelli WP (1988) Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol 41(3):237–242PubMedCrossRef Abbott RD, Brand FN, Kannel WB, Castelli WP (1988) Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol 41(3):237–242PubMedCrossRef
8.
go back to reference Krishnan E, Baker JF, Furst DE, Schumacher HR (2006) Gout and the risk of acute myocardial infarction. Arthritis Rheum 54(8):2688–2696PubMedCrossRef Krishnan E, Baker JF, Furst DE, Schumacher HR (2006) Gout and the risk of acute myocardial infarction. Arthritis Rheum 54(8):2688–2696PubMedCrossRef
9.
go back to reference Choi HK, Curhan G (2007) Independent impact of gout on mortality and risk for coronary heart disease. Circulation 116(8):894–900PubMedCrossRef Choi HK, Curhan G (2007) Independent impact of gout on mortality and risk for coronary heart disease. Circulation 116(8):894–900PubMedCrossRef
10.
go back to reference Kuo C-F, Yu K-H, See L-C, Chou I-J, Ko Y-S, Chang H-C, Chiou M-J, Luo S-F (2013) Risk of myocardial infarction among patients with gout: a nationwide population-based study. Rheumatology (Oxford) 52(1):111–117CrossRef Kuo C-F, Yu K-H, See L-C, Chou I-J, Ko Y-S, Chang H-C, Chiou M-J, Luo S-F (2013) Risk of myocardial infarction among patients with gout: a nationwide population-based study. Rheumatology (Oxford) 52(1):111–117CrossRef
11.
go back to reference Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B (2007) Universal definition of myocardial infarction. Eur Heart J 28(20):2525–2538PubMedCrossRef Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B (2007) Universal definition of myocardial infarction. Eur Heart J 28(20):2525–2538PubMedCrossRef
12.
go back to reference Wallace SL, Robinson H, Masi AT, Decker JL, Mccarty DJ (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20(3):895–900PubMedCrossRef Wallace SL, Robinson H, Masi AT, Decker JL, Mccarty DJ (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20(3):895–900PubMedCrossRef
13.
go back to reference Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130(6):461–470PubMedCrossRef Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130(6):461–470PubMedCrossRef
14.
go back to reference Eknoyan G, Levin NW (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1–S266 Eknoyan G, Levin NW (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1–S266
15.
go back to reference Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es G-A, Steg PG, M-al M, Mauri L, Vranckx P (2007) Clinical end points in coronary stent trials a case for standardized definitions. Circulation 115(17):2344–2351PubMedCrossRef Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es G-A, Steg PG, M-al M, Mauri L, Vranckx P (2007) Clinical end points in coronary stent trials a case for standardized definitions. Circulation 115(17):2344–2351PubMedCrossRef
17.
go back to reference Thornley S, Marshall RJ, Jackson R, Gentles D, Dalbeth N, Crengle S, Kerr A, Wells S (2013) Is serum urate causally associated with incident cardiovascular disease? Rheumatology (Oxford) 52(1):135–142CrossRef Thornley S, Marshall RJ, Jackson R, Gentles D, Dalbeth N, Crengle S, Kerr A, Wells S (2013) Is serum urate causally associated with incident cardiovascular disease? Rheumatology (Oxford) 52(1):135–142CrossRef
18.
go back to reference Krishnan E, Pandya BJ, Lingala B, Hariri A, Dabbous O (2012) Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction. Arthritis Res Ther 14(1):R10PubMedCentralPubMedCrossRef Krishnan E, Pandya BJ, Lingala B, Hariri A, Dabbous O (2012) Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction. Arthritis Res Ther 14(1):R10PubMedCentralPubMedCrossRef
19.
go back to reference Lottmann K, Chen X, Schadlich PK (2012) Association between gout and all-cause as well as cardiovascular mortality: a systematic review. Curr Rheumatol Rep 14(2):195–203PubMedCentralPubMedCrossRef Lottmann K, Chen X, Schadlich PK (2012) Association between gout and all-cause as well as cardiovascular mortality: a systematic review. Curr Rheumatol Rep 14(2):195–203PubMedCentralPubMedCrossRef
20.
go back to reference Chen SY, Chen CL, Shen ML (2007) Severity of gouty arthritis is associated with Q-wave myocardial infarction: a large-scale, cross-sectional study. Clin Rheumatol 26(3):308–313PubMedCrossRef Chen SY, Chen CL, Shen ML (2007) Severity of gouty arthritis is associated with Q-wave myocardial infarction: a large-scale, cross-sectional study. Clin Rheumatol 26(3):308–313PubMedCrossRef
21.
go back to reference Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105(9):1135–1143PubMedCrossRef Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105(9):1135–1143PubMedCrossRef
23.
go back to reference Tashiro H, Shimokawa H, Yamamoto K, Nagano M, Momohara M, Muramatu K, Takeshita A (1995) Monocyte-related cytokines in acute myocardial infarction. Am Heart J 130(3):446–452PubMedCrossRef Tashiro H, Shimokawa H, Yamamoto K, Nagano M, Momohara M, Muramatu K, Takeshita A (1995) Monocyte-related cytokines in acute myocardial infarction. Am Heart J 130(3):446–452PubMedCrossRef
24.
go back to reference Steppich BA, Moog P, Matissek C, Wisniowski N, Kuhle J, Joghetaei N, Neumann FJ, Schomig A, Ott I (2007) Cytokine profiles and T cell function in acute coronary syndromes. Atherosclerosis 190(2):443–451PubMedCrossRef Steppich BA, Moog P, Matissek C, Wisniowski N, Kuhle J, Joghetaei N, Neumann FJ, Schomig A, Ott I (2007) Cytokine profiles and T cell function in acute coronary syndromes. Atherosclerosis 190(2):443–451PubMedCrossRef
25.
go back to reference Miyao Y, Yasue H, Ogawa H, Misumi I, Masuda T, Sakamoto T, Morita E (1993) Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am Heart J 126(6):1299–1304PubMedCrossRef Miyao Y, Yasue H, Ogawa H, Misumi I, Masuda T, Sakamoto T, Morita E (1993) Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am Heart J 126(6):1299–1304PubMedCrossRef
26.
go back to reference Balbay Y, Tikiz H, Baptiste R, Ayaz S, Sasmaz H, Korkmaz S (2001) Circulating interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha, and soluble ICAM-1 in patients with chronic stable angina and myocardial infarction. Angiology 52(2):109PubMedCrossRef Balbay Y, Tikiz H, Baptiste R, Ayaz S, Sasmaz H, Korkmaz S (2001) Circulating interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha, and soluble ICAM-1 in patients with chronic stable angina and myocardial infarction. Angiology 52(2):109PubMedCrossRef
27.
go back to reference Blancke F, Claeys MJ, Jorens P, Vermeiren G, Bosmans J, Wuyts FL, Vrints CJ (2005) Systemic inflammation and reperfusion injury in patients with acute myocardial infarction. Mediators Inflamm 2005(6):385–389PubMedCentralPubMedCrossRef Blancke F, Claeys MJ, Jorens P, Vermeiren G, Bosmans J, Wuyts FL, Vrints CJ (2005) Systemic inflammation and reperfusion injury in patients with acute myocardial infarction. Mediators Inflamm 2005(6):385–389PubMedCentralPubMedCrossRef
28.
go back to reference Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E (2000) Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction. Circulation 101(18):2149–2153PubMedCrossRef Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E (2000) Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction. Circulation 101(18):2149–2153PubMedCrossRef
29.
go back to reference Krishnan E (2010) Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout. Rheumatology (Oxford) 49(7):1229–1238CrossRef Krishnan E (2010) Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout. Rheumatology (Oxford) 49(7):1229–1238CrossRef
30.
go back to reference Janssens HJEM, van de Lisdonk EH, Janssen M, van den Hoogen HJM, Verbeek ALM (2006) Gout, not induced by diuretics? A case–control study from primary care. Ann Rheum Dis 65(8):1080–1083PubMedCrossRef Janssens HJEM, van de Lisdonk EH, Janssen M, van den Hoogen HJM, Verbeek ALM (2006) Gout, not induced by diuretics? A case–control study from primary care. Ann Rheum Dis 65(8):1080–1083PubMedCrossRef
31.
go back to reference Dosman J, Crawhall J, Klassen G (1975) Uric acid kinetic studies in the immediate post-myocardial-infarction period. Metabolism 24(4):473–480PubMedCrossRef Dosman J, Crawhall J, Klassen G (1975) Uric acid kinetic studies in the immediate post-myocardial-infarction period. Metabolism 24(4):473–480PubMedCrossRef
32.
go back to reference Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A, Summaria F, Ginnetti F, Fadda G, Maseri A (1999) Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 99(7):855–860PubMedCrossRef Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A, Summaria F, Ginnetti F, Fadda G, Maseri A (1999) Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 99(7):855–860PubMedCrossRef
33.
go back to reference Grau AJ, Boddy AW, Dukovic DA, Buggle F, Lichy C, Brandt T, Hacke W (2004) Leukocyte Count as an Independent Predictor of Recurrent Ischemic Events. Stroke 35(5):1147–1152PubMedCrossRef Grau AJ, Boddy AW, Dukovic DA, Buggle F, Lichy C, Brandt T, Hacke W (2004) Leukocyte Count as an Independent Predictor of Recurrent Ischemic Events. Stroke 35(5):1147–1152PubMedCrossRef
35.
go back to reference Kuo C-F, See L-C, Yu K-H, Chou I-J, Chiou M-J, Luo S-F (2013) Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. Rheumatology (Oxford) 52(1):127–134CrossRef Kuo C-F, See L-C, Yu K-H, Chou I-J, Chiou M-J, Luo S-F (2013) Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. Rheumatology (Oxford) 52(1):127–134CrossRef
36.
go back to reference Thanassoulis G, Brophy JM, Richard H, Pilote L (2010) Gout, allopurinol use, and heart failure outcomes. Arch Intern Med 170:1358–1364PubMedCrossRef Thanassoulis G, Brophy JM, Richard H, Pilote L (2010) Gout, allopurinol use, and heart failure outcomes. Arch Intern Med 170:1358–1364PubMedCrossRef
37.
go back to reference Higgins P, Dawson J, Lees KR, McArthur K, Quinn TJ, Walters MR (2012) Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis. Cardiovasc Ther 30(4):217–226PubMedCrossRef Higgins P, Dawson J, Lees KR, McArthur K, Quinn TJ, Walters MR (2012) Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis. Cardiovasc Ther 30(4):217–226PubMedCrossRef
Metadata
Title
Acute gouty arthritis complicated with acute ST elevation myocardial infarction is independently associated with short- and long-term adverse non-fatal cardiac events
Authors
Kuan-Liang Liu
Hsin-Fu Lee
Shing-Hsien Chou
Yen-Chen Lin
Chia-Pin Lin
Chun-Li Wang
Chi-Jen Chang
Lung-An Hsu
Publication date
01-01-2014
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 1/2014
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2376-2

Other articles of this Issue 1/2014

Clinical Rheumatology 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.